Ficolins are animal lectins with collagen-like and fibrinogen-like domains. They are involved in the first line of host defense against pathogens. Human ficolin/ P35 as well as mannose-binding lectin (MBL) activates the complement lectin pathway in association with MBL-associated serine proteases. To elucidate the origin and evolution of ficolins, we separated ϳ40 kDa (p40) and ϳ50 kDa (p50) N-acetylglucosamine-binding lectins from hemolymph plasma of the solitary ascidian. Binding assays revealed that p40 recognizes N-acetyl groups in association with a pyranose ring and that p50 recognizes N-acetylglucosamine alone. Based on the amino acid sequences of the proteins, we isolated two clones each of p40 and p50 from the ascidian hepatopancreas cDNA and determined the entire coding sequences of these clones. Because all of the clones contained both collagen-like and fibrinogen-like domains, we concluded that these were homologs of the mammalian ficolin family and designated ascidian ficolins (AsFCNs). The fibrinogen-like domain of the AsFCNs shows 45.4 -52.4% amino acid sequence identity with the mammalian ficolin family. A phylogenetic tree of the fibrinogen-like sequences shows that all the fibrinogen-like domains may have evolved from a common ancestor that branched off an authentic fibrinogen. These results suggest that AsFCNs play an important role with respect to ascidian hemolymph lectin activity and the correlation of different functions with binding specificity.
for carbohydrates vary, and calcium ions are required for binding. MBL in serum has an opsonic activity (4) and the capacity to activate complement (5) . MBL is associated with serine proteases, termed MBL-associated serine proteases (MASPs), and upon binding of MBL through its carbohydrate-recognition domain to carbohydrates such as mannose or N-acetylglucosamine (GlcNAc) of pathogens, MASPs cleave complement components (6 -9) . Complement activation by MBL in association with MASPs is called the lectin pathway (7, 10) .
Ficolins are a group of proteins that consist of a collagen-like domain and a fibrinogen-like domain. They were originally identified as transforming growth factor-␤1-binding proteins on porcine uterus membrane (11) . Ficolins have been identified in mammals including human (12) (13) (14) (15) , rodents (16, 17) , pig (11) , and hedgehog (18) and have tissue-specific distributions. Serum ficolins from human, mouse, and pig are lectins with a common binding specificity for GlcNAc (12, (15) (16) (17) . It is likely that the fibrinogen-like domain of serum ficolins is responsible for carbohydrate binding (19) . In human serum, two types of ficolin, named ficolin/P35 (ficolin L) (12, 14) and ficolin H (Hakata antigen) (15) , have been identified and both of them have lectin activity. Another ficolin, termed ficolin M (14) , or P35-related protein (13) , whose mRNA is found in leukocytes and lung is not considered to be a serum protein. Recently it has been reported that ficolin M might act as a phagocytic receptor or adaptor on circulating monocytes for microorganism recognition (12) . Ficolin/P35 acts as an opsonin and enhances phagocytosis of Salmonella typhimurium by neutrophil (20) . It also activates the lectin complement pathway in association with MASPs (21) . These findings suggest that ficolins are involved in host defense through innate immunity in the vertebrate.
The molecular details of invertebrate innate immune systems and their possible connection to vertebrate innate immunity have not been fully elucidated. Ascidians occupy a pivotal intermediary position between invertebrates and vertebrates. Therefore, studies on the host defense mechanisms of ascidian could provide us with important information about the evolution of a primitive innate immune system of vertebrates. The recent identification of cDNA encoding the third component of complement (AsC3) (22), two types of MASP (AsMASPa and AsMASPb) (23) , and glucose-binding lectin (GBL) (24) suggests that the lectin complement pathway is present in ascidian, Halocynthia roretzi. This implies that lectins homologous to vertebrate MBL or ficolins might exist in ascidian. Here we describe the isolation and cloning of GlcNAc-binding lectins with a collagen-like domain and a fibrinogen-like domain, designated as ascidian ficolins (AsFCNs), from hemolymph plasma of the solitary ascidian, H. roretzi. * This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The Purification of Ascidian Ficolin-like Lectin-Hemolymph was collected from the solitary ascidian by cutting the tunic matrix without injuring internal organs, followed by centrifugation. To remove galactose-binding proteins and nonspecific binding proteins, the hemolymph plasma was directly applied to an acidified Sepharose 4B column equilibrated with starting buffer consisting of 25 mM Tris-HCl, pH 7.8, containing 1 M NaCl and 5 mM CaCl 2 . The fractions that passed through were applied to a GlcNAc-agarose column. After washing the column with starting buffer, two major proteins designated p40 and p50 were eluted with starting buffer containing 150 mM GlcNAc. The eluted fractions were dialyzed against 25 mM Tris-HCl, pH 7.8 containing, 50 mM NaCl, 5 mM CaCl 2 , and then chromatographed on a Mono Q column, followed by elution with a linear NaCl gradient to 0.5 M. The preparation was analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) using the Laemmli system.
Binding Assay of p40 and p50 with Glycoproteins and Neoglycoproteins-The ascidian ficolin-like proteins (p40 and p50) were labeled with Na 125 I and IODO-GEN from Pierce, Rockford, IL. The glycoproteins ovalbumin, bovine pancreatic RNase B, human fetuin, and human asialofetuin and the neoglycoproteins lactose-conjugated BSA (Lac-BSA), cellobiose-conjugated BSA (Cel-BSA), N-acetylglucosamine-conjugated BSA (GlcNAc-BSA), mannose-conjugated BSA (Man-BSA), glucose-conjugated BSA (Glc-BSA), galactose-conjugated BSA (Gal-BSA), N-acetylgalactosamine-conjugated BSA (GalNAc-BSA), N-acetyllactosamine-conjugated BSA (LacNAc-BSA), NeuAc␣2-3N-acetyllactosamine-conjugated BSA (Sia-LacNAc-BSA) were used for binding assays. In each neoglycoprotein, ϳ19 -42 mol of carbohydrate were conjugated to 1 mol of BSA. Ovalbumin contains high mannose-type and hybrid-type oligosaccharides (25, 26) ; RNase B, high mannose-type oligosaccharides (27) ; human fetuin and human asialofetuin, both complex-type oligosaccharides and O-linked oligosaccharides (28, 29) .
Glycoproteins and neoglycoproteins were dissolved in phosphatebuffered saline at the concentrations indicated in the figures. 100 l of each solution was dot-blotted onto a PVDF membrane (Millipore, Bedford, MA) using an Immunodot microfiltration apparatus (ATTO, Tokyo, Japan). The dotted membrane was blocked for 2 h at room temperature with 25 mM Tris-HCl buffer, pH 7.8, containing 1 M NaCl and 3% (w/v) BSA. The membrane was rinsed with 25 mM Tris-HCl buffer, pH 7.8, containing 1 M NaCl and 5 mM CaCl 2 (Buffer A) and then incubated for 2 h at 4°C with 125 I-labeled p40 (400,000 cpm/ml) or 125 I-labeled p50 (350,000 cpm/ml) in Buffer A containing 0.1% (w/v) BSA. After the incubation, the membrane was washed with Buffer A and air-dried. Binding of the radioactive ascidian lectins was measured using a Bio-imaging analyzer BAS-1800II (Fujifilm, Tokyo, Japan) and is indicated as the intensity of the photostimulated luminescence (PSL).
For inhibition assays, 100 l of each GlcNAc-BSA solution (0.00032-5.0 g/100 l) was dot-blotted onto a PVDF membrane. The membrane was blocked and rinsed as described above.
125 I-labeled p40 and p50 were preincubated for 1 h at 4°C without or with 1, 10, or 100 mM GlcNAc, 10 mM sodium acetate, or 10 mM N-acetylglycine in Buffer A containing 0.1% (w/v) BSA. The mixture was then overlaid on the membrane and binding of the radioactive lectin to the GlcNAc-BSA was determined as described above.
Binding Assay of p40 with Neoglycolipids-Neoglycolipids were prepared by reductive amination from dipalmitoyl phosphatidylethanolamine (DPPE) and the following carbohydrates as described previously (30) : GlcNAc, di-N-acetylchitobiose (GlcNAc2), tri-N-acetylchitotriose (GlcNAc3), tetra-N-acetylchitotetraose (GlcNAc4), penta-N-acetylchitopentaose (GlcNAc5), hexa-N-acetylchitohexaose (GlcNAc6), and GlcNAc␤1-2Man␣1-6(GlcNAc␤1-2Man␣1-3)Man (GlcNAc2Man3). The neoglycolipids were applied to two TLC plates (Merck, Darmstadt, Germany), chromatographed, and developed using chloroform/methanol/water (60:35:8, by volume). After drying, one TLC plate was used for the binding assay with 125 I-labeled p40 (400,000 cpm/ml). The other TLC plate was sprayed with primulin reagent and then subjected to a Lumino-image analyzer LAS-1000 (Fujifilm) for lipid detection of neoglycolipids.
Amino Acid Sequence Analysis-For amino acid sequencing, p40 or p50 was subjected to SDS-PAGE under reducing conditions and then electroblotted onto PVDF membranes. The bands were visualized by Coomassie Blue staining, excised, and then analyzed using an ABI protein sequencer model 476A. To obtain the internal amino acid sequences, p40 or p50 was digested with Staphylococcus aureus V8 protease according to Cleveland's method (31) . Digested peptides were electroblotted, followed by the same method as described above.
Cloning of p40 and p50 cDNA-Ascidian hepatopancreases were removed immediately before use. RNA was isolated from the hepatopancreases and hemocytes using the acid guanidine thiocyanate method, and the poly(A) ϩ fraction was purified by passage through an oligo (dT)-cellulose column (CLONTECH, Palo Alto, CA). cDNAs were prepared using SUPERSCRIPT TM II Reverse Transcriptase (Life Technologies, Inc., Rockville, MD).
Four degenerated primers were synthesized based on the NH 2 -terminal amino acid sequences of p40 and its V8 protease fragments: TGLRNQ (5Ј-ACNGGNYTNMGNAAYCA-3Ј), RNQLQE (5Ј-MGNAAY-CARYTNCARGA-3Ј), FQRRMD (5Ј-TCCATNCKNCKYTGRAA-3Ј), and WTVFQR (5Ј-CKYTGRAANACNGTCCA-3Ј). A nested PCR was performed to amplify a portion of the cDNA using ascidian hepatopancreas cDNA as a template and two primer sets (5Ј-ACNGGNYTNMG-NAAYCA-3Ј and 5Ј-TCCATNCKNCKYTGRAA-3Ј for the first and 5Ј-MGNAAYCARYTNCARGA-3Ј and 5Ј-CKYTGRAANACNGTCCA-3Јfor the second). PCR products of the expected size were cloned into pGEM-T easy vector (Promega, Wisconsin, WI) and sequenced. 5Ј-and 3Ј-RACE (rapid amplification of cDNA ends) were then conducted to complete the cDNA sequence using a kit (Marathon, CLONTECH). Two sets of gene-specific primers (GSPs) were synthesized: 5Ј-AGTTTCTG-TTTTCTGATCCACTCTG-3Ј and 5Ј-TGTTTTCTGATCCACTCTGTTG-TCC-3Ј for 5ЈRACE and 5Ј-CGAAGTAAGAATGGACAACAGAGTG-3Ј and 5Ј-AAGAATGGACAACAGAGTGGATCAG-3Ј for 3Ј-RACE. The RACE products were cloned and sequenced. A complete stretch of p40 cDNA was constructed by overlapping the sequences of these PCR products, and it was designated AsFCN1. We also identified another cDNA sequence, termed AsFCN2.
Four degenerated primers were synthesized for PCR to amplify the p50 cDNA. These were based on the amino acid sequences VMQKVM (5Ј-GTNATGCARAARGTNATG-3Ј), AEGVTG (5Ј-GCNGARGGNGT-NACNGG-3Ј), WTVFQR (5Ј-CKYTGRAANACNGTCCA-3Ј), and VYC-DLT (5Ј-GTNARRTCRCARTANAC-3Ј). A nested PCR was performed using ascidian hepatopancreas cDNA as a template and two primer sets (5Ј-GTNATGCARAARGTNATG-3Ј and 5Ј-CKYTGRAANACNGTCCA3Јfor the first and 5Ј-GCNGARGGNGTNACNGG-3Ј and 5Ј-GTNARRT-CRCARTANAC-3Ј for the second). PCR products of the expected size were cloned and sequenced as described. To complete the p50 cDNA sequence, 5Ј-and 3Ј-RACE were conducted using GSPs (5Ј-CTGCTAT-ACCCCTGCATCCATCAGG-3Ј and 5Ј-ACCCCTGCATCCATCAGGGA-CTTCA-3Ј for 5Ј-RACE and 5Ј-CGAACAGAGGTTGGAAATGGAAAT-C-3Ј and 5Ј-GTTGGAAATGGAAATCGAGAAGAAA-3Ј for 3ЈRACE). Its clone was designated AsFCN3. Using different sets of GSPs (5Ј-TCCT-TTCCAGGATATAGCCCCGTAC-3Ј and 5Ј-GGATATAGCCCCGTACT-TGCTCACT-3Ј for 5Ј-RACE, and 5Ј-CGCAGAAACCCAGCAA-CAAATCGTC3-Ј and 5Ј-ACCCAGCAACAAATCGTCGAAGGAA-3Ј for 3Ј-RACE), another cDNA sequence, designated AsFCN4, was identified.
Nucleotide Sequence Analysis-DNA sequences were determined by the dideoxy chain termination method (32) using a DNA sequencer (Model 4000; LI-COR, Lincoln, NE). The labeling reaction was performed using a Thermo Sequenase Cycle Sequencing kit (USB Corporation, Cleveland, OH). Sequencing primers were synthesized by Nisshinbo (Tokyo, Japan).
Northern Blot Hybridization-A membrane filter blotted with 2 g of poly(A) ϩ fraction from hepatopancreases and hemocytes was hybridized with 32 P-labeled specific cDNA fragments of the ascidian ficolins (As-FCN1, nucleotides 14 -336; AsFCN3, nucleotides 69 -384; AsFCN4, nucleotides 7-326) at 42°C overnight in 50% formamide, 5ϫ Denhardt's solution, 5ϫ SSPE (1ϫ SSPE is 9 mM sodium phosphate, 150 mM NaCl, 1 mM EDTA, pH 7.4), 0.5% SDS, and 200 g/ml salmon sperm DNA. After a final washing at 55°C for 40 min in 0.1ϫ SSC (1.5 mM sodium citrate, 15 mM NaCl, pH 7.0) containing 0.1% SDS, the filter was exposed to an autoradiogram imaging screen, and the image was then read using a bioimaging analyzing system (BAS 1000, Fujifilm).
Construction of the Phylogenetic Tree-The fibrinogen-like sequences of four ascidian ficolins, of eight members of the mammalian ficolin family, including human ficolin/P35 (12), ficolin M (13), ficolin H (15), porcine ficolin-␣ and -␤ (11), rat ficolin and mouse ficolin-A (16) and -B (17), of other proteins with a fibrinogen-like domain, and of fibrinogens were aligned using ClustalW software (EMBL Data Library, Heidelberg, Germany). A pairwise distance matrix was obtained by calculating the proportions of different amino acids. The matrix was then used to construct trees by the neighbor-joining method (33) . Bootstrap analysis was used to assess the reliability of branching patterns. For each tree, 1000 bootstrap replications were performed.
RESULTS

Purification of Ascidian Ficolin-like
Lectins, p40 and p50 -The hemolymph plasma was subjected to affinity chromatography on a GlcNAc-agarose column, and ascidian ficolin-like lectins were eluted with GlcNAc like human ficolin/P35. Two major proteins with molecular masses of ϳ40 and ϳ50 kDa by SDS-PAGE under reducing conditions were found in the eluate from GlcNAc-agarose column (Fig. 1A) and were tentatively designated p40 and p50, respectively. Further purification was achieved by ion-exchange chromatography on a Mono Q column. As shown in Fig. 1B , each fraction of purified p40 and p50 showed a single band by SDS-PAGE under reducing conditions. Under non-reducing conditions, p40 and p50 are resolved mainly into 180 and 240 kDa components and 150, 300, and 450 components, respectively. Two-dimensional electrophoresis indicated that these proteins could be reduced to ϳ40 kDa and ϳ50 kDa, respectively (data not shown). These results suggest that p40 and p50 are composed of subunits linked to form homopolymers via disulfide bonds, as is the case with human ficolin/P35.
Binding Specificity of p40 for Glycoproteins, Neoglycoproteins, and Neoglycolipids-To investigate the lectin activity of p40, its binding specificity for various glycoproteins and neoglycoproteins was evaluated. In a binding assay with neoglycoprotein, p40 bound GlcNAc-BSA, GalNAc-BSA, and Sia-LacNAc-BSA but not to the other neoglycoproteins ( Fig. 2A) . In particular, p40 recognized GlcNAc with the most sensitivity (GlcNAc Ͼ GalNAc Ͼ Sia-LacNAc). Furthermore, it was notable that p40 did not bind to LacNAc-BSA with carbohydrate structure of Gal␤1-4GlcNAc, suggesting that this lectin can recognize non-reducing terminal carbohydrate residues carrying N-acetyl group such as GlcNAc, GalNAc, and NeuAc. Another binding assay was performed with natural glycoproteins, i.e. ovalbumin (OVA) with high mannose-type and hybrid-type oligosaccharides, bovine RNase B (RN) with only high mannose-type oligosaccharides, human fetuin and human asialofetuin, both with complex-type oligosaccharides and O-linked oligosaccharides. The results showed that p40 bound to fetuin, which has oligosaccharides with N-acetylneuraminic acid at their non-reducing termini (Fig. 2B) . Furthermore, one of the simplest chemicals containing an N-acetyl groups, N-acetylglycine, inhibited p40 binding to GlcNAc-BSA (Fig. 2C) .
We next performed similar binding assays using neoglycolipids prepared by reductive amination from dipalmitoyl phosphatidylethanolamine (DPPE) and the following carbohydrates as described previously (30): GlcNAc, GlcNAc2, GlcNAc3, GlcNAc4, GlcNAc5, GlcNAc6, and GlcNAc␤1-2Man␣1-6(GlcNAc␤1-2Man␣1-3)Man (GlcNAc2Man3). These conjugates were chromatographed on a TLC plate, which was then used for a binding assay with 125 I-labeled p40. As shown in Fig. 2D , radiolabeled p40 bound to all the neoglycolipids with the exception of GlcNAc-DPPE. The failure of p40 to bind to GlcNAc-DPPE may be caused by a structural change in the pyranose ring by reductive amination from DPPE. These results suggest that carbohydrate recognition by p40 may require not only an N-acetyl group but also an intact pyranose ring structure.
Binding Specificity of p50 for Glycoproteins and Neoglycoproteins-As shown in Fig. 3A , p50 bound to GlcNAc-BSA in a dose-dependent manner and bound weakly to GalNAc-BSA, but did not bind to the others (Man-BSA, Glc-BSA, Gal-BSA, Lac-BSA, Cel-BSA, LacNAc-BSA, and Sia-LacNAc-BSA). It also did not bind to any of the glycoproteins tested (data not shown). An inhibition assay with GlcNAc showed that more than 10 mM GlcNAc completely inhibited p50 binding to GlcNAc-BSA (Fig. 3B) . Thus, it is likely that p50 exclusively recognizes GlcNAc at non-reducing terminal.
Amino Acid Sequence Analyses of p40 and p50 -The NH 2 -terminal amino acid sequences of p40 (27 amino acids) and p50 (24 amino acids) were determined. These sequences showed no significant similarity to other known proteins. In p40, the amino acid sequence, HNEDLXTGLPNQLQEHXSLPESG-VIIE, was obtained and an additional weak arginine (R) and threonine (T) appeared at positions 1 and 22 (shown in bold) of the mature protein, respectively. After fragmentation of p40 and p50 with S. aureus V8 protease, partial internal amino acid sequences were also determined. The NH 2 -terminal sequence (VYCDLTSDGGGWTVFQRRMDGSVDF) of one of the peptides from p40 was the same as that of a peptide from p50. This sequence has significant similarity to a portion of the fibrinogen-like sequences in mammalian ficolin, tenascin and fibrinogen.
cDNA Cloning of p40 and p50 -Using degenerated primers prepared based on the NH 2 -terminal amino acid sequences of p40 and p50, and those of the fragmented peptides, we performed nested PCR. The cDNA sequence completed by 5Ј-and 3Ј-RACE showed that p40 cDNA contains a 972-base pair openreading frame (ORF) encoding 324 amino acids preceded by a leader peptide of 17 amino acids, which we designated AsFCN1 (Fig. 4) . The predicted molecular size of mature AsFCN1 was calculated to be 34,799 Da. In the cDNA cloning of AsFCN1, another cDNA clone was identified with hepatopancreas cDNA. This cDNA clone, termed AsFCN2, encodes 324 amino acids, which had 92.6% identity with AsFCN1 and had the same domain structure (Fig. 4) . The p50 cDNA contains a 1,068-base pair ORF encoding 356 amino acids preceded by a leader peptide of 21 amino acids. The predicted molecular size of mature p50, designated AsFCN3, was calculated to be 38,229 Da. The   FIG. 1. SDS-PAGE of p40 and p50. A, eluate from a GlcNAc-agarose column was subjected to SDS-PAGE under reducing conditions (10% gel). B, SDS-PAGE of purified p40 and p50 under reducing (left) and non-reducing (right) conditions (a, p40; b, p50). Proteins were stained with Coomassie Brilliant Blue R-250. Molecular size markers are indicated on both sides.
overall amino acid sequence identity between AsFCN1 and AsFCN3 was 69.3%. In the cDNA cloning of AsFCN3, we also identified another clone, termed AsFCN4. AsFCN4 cDNA contains a 1023-base pair ORF encoding 341 amino acids, which has 76.2%, 69.2, and 70.9% identities to AsFCN1, 2, and 3, respectively.
Because AsFCN1 and AsFCN3 contained three and four potential N-linked glycosylation sites, respectively, the molecular sizes observed on SDS-PAGE seem to result from glycosylation. Both AsFCN1 and AsFCN3 have a short collagenous sequence, five Gly-X-Y triplet repeats (where X and Y represent any amino acid) and a COOH-terminal fibrinogen-like domain, suggesting ficolin-like lectins. As shown in Fig. 4 , alignment of the amino acid sequences of these four AsFCNs indicated that they are closely similar to each other, especially in their fibrinogen-like domains. The fibrinogen-like domain sequences of the AsFCNs showed from 45.4 to 52.4% identity with those of human ficolins.
Northern Blot Hybridization of AsFCNs-Because the fibrinogen-like domains of the AsFCNs are highly homologous, the 5Ј-UT sequences of AsFCN1, 3, and 4 were used as probes in Northern blots. As shown in Fig. 5 , the major transcripts of AsFCNs1, 3, and 4 expressed in the hepatopancreas are about 1.3, 1.4, and 1.3 kilobases long, respectively. From a comparison with the signal intensities, it appears that AsFCN3 and 4 are the major products in ascidian hepatopancreas. The faint signal observed in the AsFCN1 blot could result from both AsFCN1 and 2 transcripts because the sequences of AsFCN1 and AsFCN2 cDNAs are very similar. No detectable signals of AsFCNs were observed in Northern blots with the poly(A) ϩ fraction from ascidian hemocytes (data not shown).
Phylogenetic Tree of Ficolins, Fibrinogen-like Domain-bearing Proteins and Fibrinogens-The phylogenetic relationships
between AsFCNs and other fibrinogen-like proteins were analyzed by neighbor-joining trees using the regional amino acid sequences of their fibrinogen-like domains. As shown in Fig. 6 , all of the sequences in fibrinogen-like proteins examined such 125 I-labeled p40 and then analyzed for p40 binding as in Fig. 2A . C, inhibition of p40 binding. The neoglycoprotein, GlcNAc-BSA in 100 l was dot-blotted onto a PVDF membrane at the concentration indicated.
125 I-labeled p40 was pre-incubated without (Control) or with 10 mM sodium acetate or 10 mM N-acetylglycine and then subjected to the binding assay. D, binding of 125 I-labeled p40 to neoglycolipids. Seven neoglycolipids prepared from GlcNAc (GlcNAc-DPPE), di-N-acetylchitobiose (GlcNAc2-DPPE), tri-N-acetylchitotriose (GlcNAc3-DPPE), tetra-N-acetylchitotetraose (GlcNAc4-DPPE), penta-N-acetyl-chitopentaose (GlcNAc5-DPPE), hexa-N-acetylchitohexaose (GlcNAc6-DPPE), and GlcNAc␤1-2Man␣1-6(GlcNAc␤1-2Man␣1-3)Man (GlcNAc2Man3-DPPE) were spotted on two TLC plates and then chromatographed. One plate was overlaid with I-labeled p50 was preincubated without (Control) or with 1, 10, or 100 mM GlcNAc and then subjected to the binding assay.
as AsFCNs, mammalian ficolins, tenascins, angiopoietins, and horseshoe crab tachylectins roughly formed a single large branch. In this tree, four AsFCNs formed a tight cluster. The branch of the AsFCNs did not originate directly from that of the mammalian ficolins, which also formed independently a tight branch, making it difficult to define their origin. Members of the tenascin family also formed a unique branch between the branches of the AsFCNs and the mammalian ficolins. The phylogenetic relationship of these three groups is not convincing, because the relevant bootstrap values are not high enough to support the branching definitely. The fibrinogen-like sequences of AsFCNs were slightly more similar to those of mammalian ficolins (45-52% identity) than to those of tenascins (45-48% identity).
DISCUSSION
In this study, we isolated two novel ascidian lectins present in hemolymph from a solitary ascidian, H. roretzi by affinity chromatography using GlcNAc-agarose followed by chromatography on Mono Q, and cloned four lectins from cDNA libraries of the ascidian hepatopancreas. The deduced amino acid sequences of these ascidian lectins predict that they have major features of the mammalian ficolin family. Because these lectins contained three structural domains consisting of an NH 2 -terminal domain containing cysteine residues, a collagen-like domain, and a fibrinogen-like domain, we designated these lectins as ascidian ficolin, AsFCN 1, 2, 3, and 4. Most remarkably, these AsFCNs are the first invertebrate lectins to be identified that have characteristic collagen-like and fibrinogen-like domains. In comparison with the mammalian ficolin family, AsFCNs have shorter collagen-like domains (5 Gly-X-Y repeats, whereas those of the mammalian ficolin family contain [11] [12] [13] [14] [15] [16] [17] [18] [19] Gly-X-Y repeats). The fibrinogen-like domains of AsFCNs are 45.4 to 52.4% identical with those of the mammalian ficolin family, which also specifically recognize GlcNAc.
A phylogenetic tree based on the amino acid sequences of the fibrinogen-like domains indicated that the fibrinogen-like proteins formed a cluster independent of the primary fibrinogen sequences (Fig. 6) , suggesting that all the fibrinogen-like domains may have evolved from a common ancestor that branched off an authentic fibrinogen. In this tree, four AsFCNs form a group that is independent of the mammalian ficolin family. Another phylogenetic tree, which was constructed based on the entire amino acid sequences of AsFCNs and the mammalian ficolin family, indicated that the AsFCNs again form a tight cluster (data not shown). These results suggest that the gene duplication that produced these four genes was a recent event that most probably occurred in the tunicate lineage. The tree did not clearly define the origin of AsFCNs from a common lineage with mammalian ficolins and suggests that the fibrinogen-like domains of AsFCNs may be related to those of the tenascin family. However, the slightly higher identity of the fibrinogen-like sequences of AsFCNs with those of mammalian ficolins compared to other fibrinogen-like domains (i.e. 45-48% for tenascins, 36 -44% for angiopoietins, and 34 -42% for fibrinogens) may support a common ancestor for both ascidian and mammalian ficolins. An advanced phylogenetic tree containing the sequences of lower vertebrate ficolins that have not yet been identified may reveal the definite origin of AsFCNs.
We identified two ascidian ficolin proteins, p40 and p50. Based on the amino acid sequence of p40, we cloned AsFCN1 and AsFCN2. The alignment of the amino acid sequences of AsFCN1 and AsFCN2 showed that the NH 2 -terminal half was the same except for two amino acids, histidine (H) and serine (S) of AcFCN1, and arginine (R) and threonine (T) of AsFCN2, respectively (Fig. 4) . The latter two amino acids were also recognized as an additional signal in the amino acid sequence analysis of p40. Therefore, it is possible that p40 contains both AsFCN1 and AsFCN2. With Northern blot analysis, we showed major expression of AsFCN1, 3 and 4 transcripts in ascidian hepatopancreas (Fig. 5) . In this experiment, we could not design a specific probe for AsFCN2 because of its high similarity with AsFCN1. The message obtained with the AsFCN1 probe contained that of AsFCN2. Fig. 5 shows lower expression of AsFCN1/2 in hepatopancreas, which corresponds to the quantity of p40 in ascidian hemolymph (Fig. 1A) . On the other hand, the p50 transcript seems identical to that of the AsFCN3 transcript since a different size of AsFCN4 transcript is observed in Northern blot analysis (Fig. 5) . In this respect we have not yet identified the AsFCN4 protein.
Binding studies with neoglycoproteins, glycoproteins, and neoglycolipids indicate that p40 (AsFCN1/2) is able to bind to an N-acetyl group in association with a pyranose ring. The horseshoe crab lectins, tachylectin 5A and 5B, which have similar fibrinogen-like structures but lack collagen-like domains, also recognize the N-acetyl group (34) . In this respect p40 (AsFCN1/2) is similar to the horseshoe crab lectins, but differs in its requirement for a pyranose ring. In addition, collectin-like lectin has been identified in a different species of ascidian as a GalNAc-binding lectin with a collagen-like domain, although the complete structure has not been elucidated (35) . It is possible that this lectin and AsFCN1/2 diverged from the same ancestor and have similar physiological functions through their lectin activities. On the other hand, the binding specificity of p50 (AsFCN3) involves recognition of GlcNAc alone (Fig. 3) . Thus, each fibrinogen-like domain of AsFCNs has a lectin activity associated with a different sugar specificity. Although the AsFCNs have much shorter collagen-like sequences than the mammalian ficolins, the present study elucidated the structural and functional features common to the ascidian and mammalian ficolins, including domain structure, multimeric property, and lectin activity.
In the primitive complement system of ascidian, the activation pathway consisting of at least of C3 (21), factor B (36), and MASPs (22) has been demonstrated and corresponds to the mammalian alternative and lectin pathways. Although an ascidian MBL homolog has not been fully identified, we have identified a similar lectin, termed glucose-binding lectin (GBL), which lacks a collagen-like domain in its NH 2 -terminal region and which specifically recognizes glucose residues (23) . GBL is associated with ascidian MASPs that activate ascidian C3 (21) . Recently, we showed that human ficolin/P35, associated with MASPs, activates the lectin complement pathway (20) . Therefore, it is possible that AsFCNs function as the recognition molecule of the ascidian lectin pathway. Our preliminary experiments show that p40 (AsFCN1/2) is associated with AsMASPs and activates ascidian C3. Data are accumulating that show that the engagement of ligands by MBL or ficolin results in activation of the MASPs, which in turn activate C3 directly (6) . MASPs have been identified in lamprey (37) and ascidian (22) and C3 in ascidian (21) and sea urchin (38) . This leads to the prediction that MBL or ficolin MASPs and C3 may be the minimum ancestral components of the complement system. Thus, the identification of AsFCNs described in this report may contribute to the clarification of the primitive complement system.
